Deep Apple Therapeutics

San Francisco, California, United States

AI drug discovery Drug Discovery AI / ML Therapeutics

In a vast, unexplored virtual chemical space, Deep Apple Therapeutics moves with unprecedented speed to discover novel small molecules for high-value targets. Deep Apple combines ensemble cryo-EM to explore receptor conformations; deep learning; and the docking of multi-billion compound libraries generated using the company's proprietary Orchard.ai™ algorithm. Deep Apple's deep learning discovery engine is built upon founder expertise in computational modeling, protein and target structure determination, large-scale molecular docking, and the elucidation of protein dynamics and conformational transitions. This structure-based, machine-learning driven drug design approach enables the company to rapidly advance novel candidates addressing well-validated targets in inflammatory, metabolic, and endocrine diseases. For more information, visit deepappletx.com.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Deep Apple Therapeutics on @MedStartr Today #InflammatoryDiseases #MetabolicDiseases #EndocrineDisorders #AIDrugDiscovery #DrugDiscovery #AIML #Therapeutics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/42-IHOMu-DM

Get Involved in Deep Apple Therapeutics

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2021
Website: deepappletx.com/

Disease Areas

Inflammatory Diseases Metabolic Diseases Endocrine Disorders

Technologies

Deep LearningMachine LearningComputational Drug DiscoveryProprietary Algorithms

🌐Website

What do you think of Deep Apple Therapeutics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.